Back to today’s briefing

Story perspectives

Historic $7.4B Deal Targets Opioid Crisis Solutions

1/30/2025

50 6

Summary

Story summary

Fifteen U.S. states have struck a monumental $7.4 billion deal with Purdue Pharma and the Sackler family, marking a significant step in addressing the opioid crisis. This agreement, awaiting court approval, strips the Sacklers of their control over Purdue and halts opioid sales. The funds will be dedicated to addiction treatment and prevention, offering hope to impacted communities over the next 15 years.

1 of 1

Story summary

Fifteen U.S. states have struck a monumental $7.4 billion deal with Purdue Pharma and the Sackler family, marking a significant step in addressing the opioid crisis. This agreement, awaiting court approval, strips the Sacklers of their control over Purdue and halts opioid sales. The funds will be dedicated to addiction treatment and prevention, offering hope to impacted communities over the next 15 years.